{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:02:17Z","timestamp":1788256937948,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hunan Education Department Project","award":["20A390"],"award-info":[{"award-number":["20A390"]}]},{"name":"The Science and Technology Project of Huaihua","award":["2020R3103"],"award-info":[{"award-number":["2020R3103"]}]},{"name":"The Foundation of Hunan Provincial Natural Science","award":["2021JJ30540"],"award-info":[{"award-number":["2021JJ30540"]}]},{"name":"The Foundation of Hunan Double First-rate Discipline Construction Projects of Bioengineering"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00931-z","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T18:08:36Z","timestamp":1667498916000},"page":"1751-1761","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Untargeted metabolomics identifies potential serum biomarkers associated with Crohn\u2019s disease"],"prefix":"10.1007","volume":"23","author":[{"given":"Bo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"issue":"5","key":"931_CR1","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1053\/j.gastro.2021.09.076","volume":"162","author":"LC Berre","year":"2021","unstructured":"Berre LC, Ricciuto A, Peyrin-Biroulet L, et al. Evolving short- and long-term goals of management of IBD: getting it right, making it last. Gastroenterology. 2021;162(5):1424\u201338.","journal-title":"Gastroenterology"},{"issue":"1","key":"931_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/PAP.0000000000000325","volume":"29","author":"B Kovari","year":"2022","unstructured":"Kovari B, Bothori A, Friedman MS, et al. Histologic diagnosis of inflammatory bowel diseases. Adv Anat Pathol. 2022;29(1):48\u201361.","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"931_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/01.NPR.0000798212.61425.4f","volume":"46","author":"EF Snyder","year":"2021","unstructured":"Snyder EF, Davis S, Aldrich K, et al. Crohn disease: Identification, diagnosis, and clinical management. Nurse Pract. 2021;46(12):22\u201330.","journal-title":"Nurse Pract"},{"issue":"3","key":"931_CR4","doi-asserted-by":"publisher","first-page":"e00015","DOI":"10.14309\/ctg.0000000000000015","volume":"10","author":"S Huang","year":"2019","unstructured":"Huang S, Ben-Horin S, Mao R, et al. Mucosal healing is associated with the reduced disabling disease in Crohn\u2019s disease. Clin Transl Gastroenterol. 2019;10(3):e00015.","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"931_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/ibd\/izab318","volume":"28","author":"JJ Ashton","year":"2022","unstructured":"Ashton JJ, Boukas K, Stafford IS, Cheng G, et al. Deleterious genetic variation across the NOD signaling pathway is associated with reduced NFKB signaling transcription and upregulation of alternative inflammatory transcripts in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2022;28(6):912\u201322.","journal-title":"Inflamm Bowel Dis"},{"key":"931_CR6","doi-asserted-by":"publisher","first-page":"733433","DOI":"10.3389\/fnut.2021.733433","volume":"8","author":"CS Antoniussen","year":"2021","unstructured":"Antoniussen CS, Rasmussen HH, Holst M, et al. Reducing disease activity of inflammatory bowel disease by consumption of plant-based foods and nutrients. Front Nutr. 2021;8:733433.","journal-title":"Front Nutr"},{"issue":"5","key":"931_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/ibd\/izac016","volume":"28","author":"K Perez","year":"2021","unstructured":"Perez K, Ngollo M, Rabinowitz K, et al. Meta-analysis of IBD Gut samples gene expression identifies specific markers of ileal and colonic diseases. Inflamm Bowel Dis. 2021;28(5):816.","journal-title":"Inflamm Bowel Dis"},{"key":"931_CR8","doi-asserted-by":"publisher","first-page":"755650","DOI":"10.3389\/fcimb.2021.755650","volume":"11","author":"L Qv","year":"2021","unstructured":"Qv L, Mao S, Li Y, et al. Roles of gut bacteriophages in the pathogenesis and treatment of inflammatory bowel disease. Front Cell Infect Microbiol. 2021;11:755650.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"931_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3390\/ijms22030985","volume":"22","author":"G Caioni","year":"2021","unstructured":"Caioni G, Viscido A, Angelo M, et al. Inflammatory bowel disease: new insights into the interplay between environmental factors and PPARgamma. Int J Mol Sci. 2021;22(3):985.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"931_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa EA, Sirota-Madi A, Avila-Pacheco J, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293\u2013305.","journal-title":"Nat Microbiol"},{"issue":"3","key":"931_CR11","first-page":"321","volume":"11","author":"KL Kolho","year":"2017","unstructured":"Kolho KL, Pessia A, Jaakkola J, et al. Faecal and serum metabolomics in paediatric inflammatory bowel disease. J Crohns Colitis. 2017;11(3):321\u201334.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"931_CR12","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s10620-012-2127-2","volume":"57","author":"HR Williams","year":"2012","unstructured":"Williams HR, Willsmore JD, Cox IJ, et al. Serum metabolic profiling in inflammatory bowel disease. Dig Dis Sci. 2012;57(8):2157\u201365.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"931_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11306-017-1311-y","volume":"14","author":"EA Scoville","year":"2018","unstructured":"Scoville EA, Allaman MM, Brown CT, et al. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn\u2019s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics. 2018;14(1):17.","journal-title":"Metabolomics"},{"issue":"6","key":"931_CR14","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want EJ, Wilson ID, Gika H, et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc. 2010;5(6):1005\u201318.","journal-title":"Nat Protoc"},{"issue":"W1","key":"931_CR15","doi-asserted-by":"publisher","first-page":"W486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46(W1):W486\u201394.","journal-title":"Nucleic Acids Res"},{"key":"931_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2017.11.030","volume":"1071","author":"C Junot","year":"2017","unstructured":"Junot C, Witting M, et al. Identification of molecules from non-targeted analysis. J Chromatogr B Anal Technol Biomed Life Sci. 2017;1071:1\u20132.","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"1","key":"931_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/bmc.3864","volume":"31","author":"H Mizuno","year":"2017","unstructured":"Mizuno H, Ueda K, Kobayashi Y, et al. The great importance of normalization of LC-MS data for highly-accurate non-targeted metabolomics. Biomed Chromatogr. 2017;31(1):555.","journal-title":"Biomed Chromatogr."},{"issue":"2","key":"931_CR18","doi-asserted-by":"publisher","first-page":"107797","DOI":"10.1016\/j.jdiacomp.2020.107797","volume":"35","author":"J Yang","year":"2021","unstructured":"Yang J, Wei T, Wang K, et al. Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes. J Diabetes Complicat. 2021;35(2):107797.","journal-title":"J Diabetes Complicat"},{"key":"931_CR19","doi-asserted-by":"publisher","first-page":"114989","DOI":"10.1016\/j.jep.2022.114989","volume":"288","author":"J Wang","year":"2022","unstructured":"Wang J, Wang X, Ma X, et al. Therapeutic effect of Patrinia villosa on TNBS-induced ulcerative colitis via metabolism, vitamin D receptor and NF-\u03baB signaling pathways. J Ethnopharmacol. 2022;288:114989.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"931_CR20","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/jgh.15067","volume":"35","author":"S Iwatani","year":"2020","unstructured":"Iwatani S, Iijima H, Otake Y, et al. Novel mass spectrometry-based comprehensive lipidomic analysis of plasma from patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2020;35(8):1355\u201364.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"931_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3390\/molecules24030449","volume":"24","author":"Y Lai","year":"2019","unstructured":"Lai Y, Iijima H, Otake Y, et al. Serum metabolomics identifies altered bioenergetics, signaling cascades in parallel with exposome markers in Crohn\u2019s disease. Molecules. 2019;24(3):449.","journal-title":"Molecules"},{"issue":"21","key":"931_CR22","doi-asserted-by":"publisher","first-page":"11682","DOI":"10.3390\/ijms222111682","volume":"22","author":"LV Boldyreva","year":"2021","unstructured":"Boldyreva LV, Morozova MV, Saydakova SS, et al. Fat of the gut: epithelial phospholipids in inflammatory bowel diseases. Int J Mol Sci. 2021;22(21):11682.","journal-title":"Int J Mol Sci"},{"issue":"16","key":"931_CR23","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.3390\/ijms22169096","volume":"22","author":"MA Bromke","year":"2021","unstructured":"Bromke MA, Krzystek-Korpacka M. Bile acid signaling in inflammatory bowel disease. Int J Mol Sci. 2021;22(16):9096.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"931_CR24","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/MEG.0000000000001976","volume":"33","author":"SO Adegbola","year":"2021","unstructured":"Adegbola SO, Sarafian M, Sahnan K, et al. Differences in amino acid and lipid metabolism distinguish Crohn\u2019s from idiopathic\/cryptoglandular perianal fistulas by tissue metabonomic profiling and may offer clues to underlying pathogenesis. Eur J Gastroenterol Hepatol. 2021;33(12):1469\u201379.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"931_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3748\/wjg.v20.i1.163","volume":"20","author":"T Dawiskiba","year":"2014","unstructured":"Dawiskiba T, Deja S, Mulak A, et al. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J Gastroenterol. 2014;20(1):163\u201374.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"931_CR26","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3390\/nu13082716","volume":"13","author":"M Salaga","year":"2021","unstructured":"Salaga M, Bartoszek A, Binienda A, et al. Activation of free fatty acid receptor 4 affects intestinal inflammation and improves colon permeability in mice. Nutrients. 2021;13(8):2716.","journal-title":"Nutrients"},{"issue":"1","key":"931_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/acs.jproteome.0c00462","volume":"20","author":"D Horta","year":"2021","unstructured":"Horta D, Moreno-Torres M, Ram\u00edrez-L\u00e1zaro MJ, et al. Analysis of the association between fatigue and the plasma lipidomic profile of inflammatory bowel disease patients. J Proteome Res. 2021;20(1):381\u201392.","journal-title":"J Proteome Res"},{"issue":"37","key":"931_CR28","doi-asserted-by":"publisher","first-page":"27155","DOI":"10.1074\/jbc.M704408200","volume":"282","author":"I Treede","year":"2007","unstructured":"Treede I, Braun A, Sparla R, et al. Anti-inflammatory effects of phosphatidylcholine. J Biol Chem. 2007;282(37):27155\u201364.","journal-title":"J Biol Chem"},{"issue":"11","key":"931_CR29","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/ibd\/izz098","volume":"25","author":"J Diab","year":"2019","unstructured":"Diab J, Hansen T, Goll R, et al. Lipidomics in ulcerative colitis reveal alteration in mucosal lipid composition associated with the disease state. Inflamm Bowel Dis. 2019;25(11):1780\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"931_CR30","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/MIB.0000000000000394","volume":"21","author":"F Fan","year":"2015","unstructured":"Fan F, Mundra PA, Fang L, et al. Lipidomic profiling in inflammatory bowel disease: comparison between ulcerative colitis and Crohn\u2019s disease. Inflamm Bowel Dis. 2015;21(7):1511\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"931_CR31","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DPB, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet. 2010;42(12):1118\u201325.","journal-title":"Nat Genet"},{"key":"931_CR32","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1038\/ncomms11726","volume":"7","author":"EA Ra","year":"2016","unstructured":"Ra EA, Lee TA, Kim SW, et al. TRIM31 promotes Atg5\/Atg7-independent autophagy in intestinal cells. Nat Commun. 2016;7:11726.","journal-title":"Nat Commun"},{"issue":"5","key":"931_CR33","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s10620-012-2508-6","volume":"58","author":"K Uchiyama","year":"2013","unstructured":"Uchiyama K, Odahara S, Nakamura M, et al. The fatty acid profile of the erythrocyte membrane in initial-onset inflammatory bowel disease patients. Dig Dis Sci. 2013;58(5):1235\u201343.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"931_CR34","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.4049\/jimmunol.0902926","volume":"185","author":"S Jozefowski","year":"2010","unstructured":"Jozefowski S, Czerkies M, \u0141ukasik A, et al. Ceramide and ceramide 1-phosphate are negative regulators of TNF-alpha production induced by lipopolysaccharide. J Immunol. 2010;185(11):6960\u201373.","journal-title":"J Immunol"},{"issue":"1","key":"931_CR35","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/s41598-018-20102-z","volume":"8","author":"K Helke","year":"2018","unstructured":"Helke K, Angel P, Lu P, et al. Ceramide synthase 6 deficiency enhances inflammation in the DSS model of colitis. Sci Rep. 2018;8(1):1627.","journal-title":"Sci Rep"},{"issue":"2","key":"931_CR36","doi-asserted-by":"publisher","first-page":"158854","DOI":"10.1016\/j.bbalip.2020.158854","volume":"1866","author":"M Alhouayek","year":"2021","unstructured":"Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases-from pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(2):158854.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"3","key":"931_CR37","doi-asserted-by":"publisher","first-page":"e16953","DOI":"10.1371\/journal.pone.0016953","volume":"6","author":"S Angulo","year":"2011","unstructured":"Angulo S, Morales A, Danese S, et al. Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase. PLoS ONE. 2011;6(3):e16953.","journal-title":"PLoS ONE"},{"issue":"12","key":"931_CR38","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1021\/pr2007973","volume":"10","author":"P Baur","year":"2011","unstructured":"Baur P, Martin F, Gruber L, et al. Metabolic phenotyping of the Crohn\u2019s disease-like IBD etiopathology in the TNF(DeltaARE\/WT) mouse model. J Proteome Res. 2011;10(12):5523\u201335.","journal-title":"J Proteome Res"},{"issue":"11","key":"931_CR39","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.biocel.2012.06.016","volume":"44","author":"GW Sewell","year":"2012","unstructured":"Sewell GW, Martin F, Gruber L, et al. Lipidomic profiling in Crohn\u2019s disease: abnormalities in phosphatidylinositols, with preservation of ceramide, phosphatidylcholine and phosphatidylserine composition. Int J Biochem Cell Biol. 2012;44(11):1839\u201346.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"931_CR40","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.3390\/metabo8040082","volume":"8","author":"A Alghamdi","year":"2018","unstructured":"Alghamdi A, Martin F, Gruber L, et al. Untargeted metabolomics of extracts from faecal samples demonstrates distinct differences between paediatric Crohn\u2019s disease patients and healthy controls but no significant changes resulting from exclusive enteral nutrition treatment. Metabolites. 2018;8(4):5523\u201335.","journal-title":"Metabolites"},{"issue":"1","key":"931_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molmed.2018.10.009","volume":"25","author":"J Kurz","year":"2019","unstructured":"Kurz J, Parnham MJ, Geisslinger G, et al. Ceramides as novel disease biomarkers. Trends Mol Med. 2019;25(1):20\u201332.","journal-title":"Trends Mol Med"},{"issue":"6","key":"931_CR42","first-page":"579","volume":"10","author":"S Fiorucci","year":"2010","unstructured":"Fiorucci S, Cipriani S, Mencarelli A, et al. Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Curr Mol Med. 2010;10(6):579\u201395.","journal-title":"Curr Mol Med"},{"key":"931_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.phrs.2015.12.007","volume":"104","author":"BL Copple","year":"2016","unstructured":"Copple BL, Li T. Pharmacology of bile acid receptors: evolution of bile acids from simple detergents to complex signaling molecules. Pharmacol Res. 2016;104:9\u201321.","journal-title":"Pharmacol Res"},{"issue":"5","key":"931_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/labinvest.2017.6","volume":"97","author":"LVD Bossche","year":"2017","unstructured":"Bossche LVD, Borsboom D, Devriese S, et al. Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn\u2019s disease-like ileitis. Lab Invest. 2017;97(5):519\u201329.","journal-title":"Lab Invest"},{"key":"931_CR45","doi-asserted-by":"publisher","first-page":"727681","DOI":"10.3389\/fmicb.2021.727681","volume":"12","author":"Z Zhai","year":"2021","unstructured":"Zhai Z, Niu K, Liu Y, et al. The gut microbiota-bile acids-TGR5 axis mediates eucommia ulmoides leaf extract alleviation of injury to colonic epithelium integrity. Front Microbiol. 2021;12:727681.","journal-title":"Front Microbiol"},{"issue":"4","key":"931_CR46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbrc.2011.05.043","volume":"409","author":"E Berger","year":"2011","unstructured":"Berger E, Haller D. Structure-function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells. Biochem Biophys Res Commun. 2011;409(4):610\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"931_CR47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","volume":"62","author":"H Duboc","year":"2013","unstructured":"Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62(4):531\u20139.","journal-title":"Gut"},{"issue":"7","key":"931_CR48","first-page":"e02766","volume":"83","author":"LVD Bossche","year":"2017","unstructured":"Bossche LVD, Hindryckx P, Devisscher L, et al. Ursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice. appl Environ Microbiol. 2017;83(7):e02766-e2816.","journal-title":"appl Environ Microbiol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T13:02:58Z","timestamp":1693141378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["931"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00931-z","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}